The Risk of BK-Virus Hemorrhagic Cystitis in the Era of Post-Transplantation Cyclophosphamide

Key Points

• Hemorrhagic cystitis risk is elevated following transplantation with cyclophosphamide use, indicating a need for close monitoring.
• Increased incidence of BK-virus-related complications was noted in patients receiving cyclophosphamide treatment post-transplant.
• This analysis included a comprehensive review of transplant patient records focusing on viral infections and immunosuppression effects.
• These findings emphasize the need for revised guidelines to address complications post-transplant therapy.